Verification of the Short-Term Impact of Imeglimin on Liver Fibrosis Markers Stratified by Liver Fibrosis Risk in Patients With Type 2 Diabetes - Tanaka, Takumi; Kitao, Takashi; Kubori, Motohiro; Komoda, Yoshio; Mori, Yukiko; Ibata, Takeshi (Curēus (Palo Alto, CA), 2025)
Keywords: Body mass index; Cardiovascular disease; Cholesterol; Diabetes; Endocrinology/Diabetes/Metabolism; Fatty liver; Hemoglobin; Insulin; Internal Medicine; Kidney diseases; Kruskal-Wallis test; Laboratories; Lipoproteins; Liver cirrhosis; Liver diseases; Medical prognosis; Metabolism; Mortality; Patients; Variables; fib-4 index; imeglimin; masld; type 2 diabetes; apri